SCHEMBL10811690

SCHEMBL10811690

COC(=O)OCCCOC(O)n1cnc2cnc(N(C)C)nc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP1 P29466 20/20 0.42
▸ CASP7 P55210 20/20 0.42
▸ CYP1A2 P05177 19/20 0.42
▸ CLK4 Q9HAZ1 5/20 0.42
▸ ALDH1A1 P00352 16/20 0.38
▸ HSD17B10 Q99714 14/20 0.38
▸ CYP2D6 P10635 8/20 0.38
▸ HPGD P15428 4/20 0.38
▸ CYP3A4 P08684 8/20 0.37
▸ TSHR P16473 8/20 0.37
▸ CYP2C9 P11712 7/20 0.37
▸ CYP2C19 P33261 6/20 0.37
▸ HIF1A Q16665 5/20 0.37
▸ GLA P06280 3/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ MEN1 O00255 6/20 0.36
▸ KMT2A Q03164 6/20 0.36
▸ USP2 O75604 4/20 0.36
▸ BRCA1 P38398 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9584155 0.84 CASP1 (0.41) CASP1CASP7CYP1A2CLK4ALDH1A1
SCHEMBL10813330 0.81 CYP1A2 (0.36) CASP1CASP7CYP1A2CLK4ALDH1A1
SCHEMBL9582812 0.75 ALDH1A1 (0.41) CASP1CASP7CYP1A2CLK4ALDH1A1
SCHEMBL10817902 0.74 KDM4E (0.42) ALDH1A1HSD17B10HPGD
SCHEMBL10811698 0.71 PDE3A (0.42) CASP1CASP7CYP1A2CLK4ALDH1A1
SCHEMBL10818132 0.70 ADORA2A (0.48) CYP1A2ALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL10848496 0.70 HDAC1 (0.38) MAPK1
SCHEMBL18510348 0.69 CYP1A2 (0.50) CASP1CASP7CYP1A2CLK4ALDH1A1
SCHEMBL9583556 0.68 CDK1 (0.37) CASP1CASP7CYP1A2CLK4ALDH1A1
SCHEMBL10813342 0.68 CYP1A2 (0.38) CASP1CASP7CYP1A2CLK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0105135-B1 SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS SYNTEX (U.S.A.) INC. (US) 1987-03-18 — — EP disclosed
US-4609661-A HERPES VIRUS SYNTEX (U.S.A.) INC. (US) 1986-09-02 — — US disclosed
US-4556659-A Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1985-12-03 — — US disclosed
EP-0105135-A1 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-11 — — EP disclosed
Send feedback